CSIMarket
 
Zynex inc   (NASDAQ: ZYXI)
 
Price: $0.1250 $-0.08 -37.904%
Day's High: $0.1996 Week Perf: -52.62 %
Day's Low: $ 0.12 30 Day Perf: -79.77 %
Volume (M): 30,646,888 52 Wk High: $ 2.10
Volume (M$): $ 3,831 52 Wk Avg: $1.06
Open: $0.20 52 Wk Low: $0.12



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 30
 Employees 350
 Revenues (TTM) (Millions $) 108
 Net Income (TTM) (Millions $) -74
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 1

Business Description


Zynex Inc. is a medical device manufacturing company based in Lone Tree, Colorado, U.S.A. It was founded in 1996 by Thomas Sandgaard, who is currently the CEO and Chairman of the Board of Directors. Zynex specializes in the design, manufacture, and distribution of electrotherapy devices and other medical devices for pain management, rehabilitation, and neurological diagnostics.

The company has a broad range of products that cater to the needs of various patient populations. Its electrotherapy devices, which are its primary product line, are designed to relieve pain, treat muscle spasms, and promote tissue healing using electric currents. The electrotherapy devices include the NexWave, which is a non-invasive nerve stimulation system that provides pain relief, and the InWave, which is used for muscle rehabilitation and toning.

Zynex also manufactures and distributes the NeuroMove, a device that uses electrical stimulation to help people with paralysis and other neurological disorders improve their muscle function, and the Blood Volume Monitor, which is used by physicians to monitor blood volume during surgery and other medical procedures.

In addition to its product offerings, Zynex provides a range of services to healthcare providers, including training, support, and consulting services. The company has a team of experienced clinicians who assist healthcare providers in the selection, use, and maintenance of its medical devices.

Zynex has established itself as a leading player in the medical device industry, with its products being used by healthcare providers in the United States, Canada, and Mexico. The company has a strong commitment to research and development, and it invests heavily in clinical trials and other research initiatives to improve the quality and efficacy of its products.

Overall, Zynex Inc. is a highly reputable and innovative medical device manufacturing company that is committed to improving patient outcomes through the design and distribution of high-quality, safe, and effective medical devices.


   Company Address: 9655 Maroon Cir Englewood 80112
   Company Phone Number: 495-6670   Stock Exchange / Ticker: NASDAQ ZYXI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        1.74% 
BSX        0.84% 
IRIX        1.52% 
LNSR   -6.97%    
OSUR        9.54% 
SRTS   -3.17%    
• View Complete Report
   



Announcement

Legal Turmoil for Zynex, Inc. Investors Seek Justice Amidst Dismal Financials

Published Fri, Apr 4 2025 8:37 AM UTC

In a shocking development that underscores the fragility of investor confidence, Zynex, Inc. (NASDAQ: ZYXI) finds itself at the center of a class-action lawsuit filed by the Gross Law Firm. This legal action comes in the wake of a troubling performance report that has left investors scrambling for answers and accountability.On April 03, 2025, shareholders of Zynex, Inc. a pl...

Announcement

Dark Clouds Over Zynex Allegations of Fraud Bring Class Action Lawsuit to Light

Published Tue, Mar 25 2025 5:24 PM UTC

In a striking turn of events, Zynex, Inc. (NASDAQ: ZYXI), a company that has garnered attention for its medical device innovations, now finds itself ensnared in legal turmoil. A class action lawsuit has been filed against the company, alleging serious wrongdoing that could shake the foundations of its financial credibility. On March 25, 2025, Holzer & Holzer, LLC announced t...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.04
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.18
Working Capital Ratio 0.5
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.43 $
Revenues (TTM) 3.57 $
Cash Flow (TTM) -
Cash 0.44 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 309,294
Net Income per Employee (TTM) -211,309
Receivable Turnover Ratio (TTM) 8.82
Inventory Turnover Ratio (TTM) 2.38
Asset Turnover Ratio (TTM) 1.24

Profitability Ratios Current
Gross Margin (MRQ) 60.47 %
Operating Margin (MRQ) -329.06 %
Net Margin (MRQ) -321.21 %
Net Cash Flow Margin (MRQ) -32.07 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Zynex Inc's Segments
Device revenue    52.82 % of total Revenue
Supplies revenue    47.18 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.